Chronic graft versus host disease (cGVHD) is the most common late complication of allogeneic bone marrow transplantation. The oral cavity is the most common site of cGVHD involvement. This study sought to investigate the incidence of oral cGVHD, as well as the disease's impact on a patient's quality of life and the kind of lesions that resulted. Nineteen patients with cGVHD received a medical and dental evaluation; 18 (94.7%) had oral lesions. Nine patients (47.3%) demonstrated xerostomia and 6 (35.2%) demonstrated dysphagia. Six patients (35.2%) had a lichenoid clinical form of cGVHD in the oral cavity, 6 (35.2%) had an atrophic-ulcerative clinical form, 3 (17.6%) had a hyperceratotic clinical form, and 2 (10.5%) had mixed forms. The resul...
AbstractOral chronic graft-versus-host disease (cGVHD) is a significant and serious complication fol...
ABSTRACTBackgroundChronic graft-versus-host disease is a serious complication of allogeneic hematopo...
© 2017 Dr. Katrusha Mihalyna HullPurpose: Allogeneic hematopoietic stem cell transplantation (HSCT),...
Graft versus host disease (GVHD) is one of the most frequent and serious complications of hematopoie...
Graft versus host disease (GVHD) is one of the most frequent and serious complications of hematopoie...
ABSTRACTBackgroundChronic graft-versus-host disease is a serious complication of allogeneic hematopo...
Graft versus host disease (GVHD) is a common complication in bone marrow transplant (BMT) patients. ...
Objectives. Chronic Graft-Versus-Host Disease (cGVHD) is an immunoregulatory disorder which occurs a...
AbstractFanconi anemia (FA) is a genetic disease that is characterized by several congenital abnorma...
AbstractChronic graft-versus-host disease (cGVHD) is a serious and potentially life-threatening comp...
Graft versus host disease (GVHD) oceurs after a hematopoietic stem cell transplantation (HSCT) when ...
Objectives. Chronic Graft-Versus-Host Disease (cGVHD) is an immunoregulatory disorder which occurs a...
AbstractChronic graft-versus-host disease (cGVHD) is a serious and potentially life-threatening comp...
AbstractOral chronic graft-versus-host disease (cGVHD) is a significant and serious complication fol...
Background: Chronic graft-versus-host disease is a serious complication of allogeneic hematopoietic ...
AbstractOral chronic graft-versus-host disease (cGVHD) is a significant and serious complication fol...
ABSTRACTBackgroundChronic graft-versus-host disease is a serious complication of allogeneic hematopo...
© 2017 Dr. Katrusha Mihalyna HullPurpose: Allogeneic hematopoietic stem cell transplantation (HSCT),...
Graft versus host disease (GVHD) is one of the most frequent and serious complications of hematopoie...
Graft versus host disease (GVHD) is one of the most frequent and serious complications of hematopoie...
ABSTRACTBackgroundChronic graft-versus-host disease is a serious complication of allogeneic hematopo...
Graft versus host disease (GVHD) is a common complication in bone marrow transplant (BMT) patients. ...
Objectives. Chronic Graft-Versus-Host Disease (cGVHD) is an immunoregulatory disorder which occurs a...
AbstractFanconi anemia (FA) is a genetic disease that is characterized by several congenital abnorma...
AbstractChronic graft-versus-host disease (cGVHD) is a serious and potentially life-threatening comp...
Graft versus host disease (GVHD) oceurs after a hematopoietic stem cell transplantation (HSCT) when ...
Objectives. Chronic Graft-Versus-Host Disease (cGVHD) is an immunoregulatory disorder which occurs a...
AbstractChronic graft-versus-host disease (cGVHD) is a serious and potentially life-threatening comp...
AbstractOral chronic graft-versus-host disease (cGVHD) is a significant and serious complication fol...
Background: Chronic graft-versus-host disease is a serious complication of allogeneic hematopoietic ...
AbstractOral chronic graft-versus-host disease (cGVHD) is a significant and serious complication fol...
ABSTRACTBackgroundChronic graft-versus-host disease is a serious complication of allogeneic hematopo...
© 2017 Dr. Katrusha Mihalyna HullPurpose: Allogeneic hematopoietic stem cell transplantation (HSCT),...